Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.

Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes parkinsonism in humans and subhuman primates, but not in rats and many other laboratory animals; mice are intermediate in their susceptibility. Since MPTP causes selective dopaminergic neurotoxicity when infused di...

Descripció completa

Dades bibliogràfiques

Publicat a:	Proc Natl Acad Sci U S A
Autors principals:	Kalaria, R N, Mitchell, M J, Harik, S I
Format:	Artigo
Idioma:	Inglês
Publicat:	National Academy of Sciences 1987
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC304903/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3495000/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.84.10.3521
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!